Human osteoclasts/osteoblasts 3D dynamic co‑culture system to study the beneficial effects of glucosamine on bone microenvironment

Lambertini,Elisabetta; Penolazzi,Letizia; Pandolfi,Assunta; Mandatori,Domitilla; Sollazzo,Vincenzo; Piva,Roberta

doi:10.3892/ijmm.2021.4890

Human osteoclasts/osteoblasts 3D dynamic co‑culture system to study the beneficial effects of glucosamine on bone microenvironment

Authors:
- Elisabetta Lambertini
- Letizia Penolazzi
- Assunta Pandolfi
- Domitilla Mandatori
- Vincenzo Sollazzo
- Roberta Piva
View Affiliations

Affiliations: Department of Neuroscience and Rehabilitation, University of Ferrara, I-44121 Ferrara, Italy, Department of Medical, Oral and Biotechnological Sciences, Center for Advanced Studies and Technology ‑ CAST, University G. d'Annunzio of Chieti‑Pescara, 66100 Chieti, Italy, Centro di Medicina, I-44124 Ferrara, Italy
Published online on: February 17, 2021 https://doi.org/10.3892/ijmm.2021.4890
Article Number: 57
Copyright: © Lambertini et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Glucosamine (GlcN) functions as a building block of the cartilage matrix, and its multifaceted roles in promoting joint health have been extensively investigated. However, the role of GlcN in osteogenesis and bone tissue is poorly understood, mainly due to the lack of adequate experimental models. As a result, the benefit of GlcN application in bone disorders remains controversial. In order to further elucidate the pharmacological relevance and potential therapeutic/nutraceutic efficacy of GlcN, the effect of GlcN treatment was investigated in human primary osteoclasts (hOCs) and osteoblasts (hOBs) that were cultured with two‑dimensional (2D) traditional methods or co‑cultured in a 3D dynamic system more closely resembling the in vivo bone microenvironment. Under these conditions, osteoclastogenesis was supported by hOBs and sizeable self‑assembling aggregates were obtained. The differentiated hOCs were evaluated using tartrate‑resistant acid phosphatase assays and osteogenic differentiation was monitored by analyzing mineral matrix deposition via Alizarin Red staining, with expression of specific osteogenic markers determined via reverse transcription‑quantitative PCR. It was found that crystalline GlcN sulfate was effective in decreasing osteoclastic cell differentiation and function. hOCs isolated from patients with OA were more sensitive compared with those from healthy donors. Additionally, GlcN exhibited anabolic effects on hOCs both in 2D conventional cell culture and in hOC/hOB 3D dynamic co‑culture. The present study demonstrated for the first time the effectiveness of a 3D dynamic co‑culture system for characterizing the spectrum of action of GlcN on the bone microenvironment, which may pave the way for more fully determining the potential applications of a compound such as GlcN, which is positioned between pharmaceuticals and nutraceuticals. Based on the present findings, it is hypothesized that GlcN may have potential benefits in the treatment of osteopenic diseases such as osteoporosis, as well as in bone maintenance.

View Figures

View References

1	Nagaoka I, Igarashi M and Sakamoto K: Biological activities of glucosamine and its related substances. Adv Food Nutr Res. 65:337–352. 2012. View Article : Google Scholar : PubMed/NCBI
2	Varghese S, Theprungsirikul P, Sahani S, Hwang N, Yarema KJ and Elisseeff JH: Glucosamine modulates chondrocyte proliferation, matrix synthesis, and gene expression. Osteoarthritis Cartilage. 15:59–68. 2007. View Article : Google Scholar
3	Reily C, Stewart TJ, Renfrow MB and Novak J: Glycosylation in health and disease. Nat Rev Nephrol. 15:346–366. 2019. View Article : Google Scholar : PubMed/NCBI
4	Block JA, Oegema TR, Sandy JD and Plaas A: The effects of oral glucosamine on joint health: Is a change in research approach needed? Osteoarthritis Cartilage. 18:5–11. 2010. View Article : Google Scholar
5	Agiba AM: Nutraceutical formulations containing glucosamine and chondroitin sulphate in the treatment of osteoarthritis: Emphasis on clinical efficacy and formulation challenges. Int J Curr Pharm Res. 9:1–7. 2017. View Article : Google Scholar
6	Ostojic SM, Arsic M, Prodanovic S, Vukovic J and Zlatanovic M: Glucosamine administration in athletes: Effects on recovery of acute knee injury. Res Sports Med. 15:113–124. 2007. View Article : Google Scholar : PubMed/NCBI
7	D'Adamo S, Cetrullo S, Panichi V, Mariani E, Flamigni F and Borzì RM: Nutraceutical activity in osteoarthritis biology: A focus on the nutrigenomic role. Cells. 9:12322020. View Article : Google Scholar :
8	Ragle RM and Sawitzke AD: Nutraceuticals in the management of osteoarthritis: A critical review. Drugs Aging. 29:717–731. 2012. View Article : Google Scholar : PubMed/NCBI
9	Rovati LC, Girolami F and Persiani S: Crystalline glucosamine sulfate in the management of knee osteoarthritis: Efficacy, safety, and pharmacokinetic properties. Ther Adv Musculoskelet Dis. 4:167–180. 2012. View Article : Google Scholar : PubMed/NCBI
10	Goldring SR and Goldring MB: Changes in the osteochondral unit during osteoarthritis: Structure, function and cartilage-bone crosstalk. Nat Rev Rheumatol. 12:632–644. 2016. View Article : Google Scholar : PubMed/NCBI
11	Im GI and Kim MK: The relationship between osteoarthritis and osteoporosis. J Bone Miner Metab. 32:101–109. 2014. View Article : Google Scholar
12	Tat SK, Pelletier JP, Vergés J, Lajeunesse D, Montell E, Fahmi H, Lavigne M and Martel-Pelletier J: Chondroitin and glucosamine sulfate in combination decrease the pro-resorptive properties of human osteoarthritis subchondral bone osteoblasts: A basic science study. Arthritis Res Ther. 9:R1172007. View Article : Google Scholar : PubMed/NCBI
13	Anastassiades T, Rees-Milton K, Xiao H, Yang X, Willett T and Grynpas M: N-acylated glucosamines for bone and joint disorders: Effects of N-butyryl glucosamine on ovariectomized rat bone. Transl Res. 162:93–101. 2013. View Article : Google Scholar : PubMed/NCBI
14	Igarashi M, Sakamoto K and Nagaoka I: Effect of glucosamine, a therapeutic agent for osteoarthritis, on osteoblastic cell differentiation. Int J Mol Med. 28:373–379. 2011.PubMed/NCBI
15	Penolazzi L, Lolli A, Sardelli L, Angelozzi M, Lambertini E, Trombelli L, Ciarpella F, Vecchiatini R and Piva R: Establishment of a 3D-dynamic osteoblasts-osteoclasts co-culture model to simulate the jawbone microenvironment in vitro. Life Sci. 152:82–93. 2016. View Article : Google Scholar : PubMed/NCBI
16	Penolazzi L, Pocaterra B, Tavanti E, Lambertini E, Vesce F, Gambari R and Piva R: Human osteoclasts differentiated from umbilical cord blood precursors are less prone to apoptotic stimuli than osteoclasts from peripheral blood. Apoptosis. 13:553–561. 2008. View Article : Google Scholar : PubMed/NCBI
17	Lambertini E, Penolazzi L, Angelozzi M, Grassi F, Gambari L, Lisignoli G, De Bonis P, Cavallo M and Piva R: The expression of cystathionine gamma-lyase is regulated by estrogen receptor alpha in human osteoblasts. Oncotarget. 8:101686–101696. 2017. View Article : Google Scholar : PubMed/NCBI
18	Wrobel E, Leszczynska J and Brzoska E: The characteristics of human bone-derived cells (HBDCS) during osteogenesis in vitro. Cell Mol Biol Lett. 21:262016. View Article : Google Scholar
19	Choudhary S, Sun Q, Mannion C, Kissin Y, Zilberberg J and Lee WY: Hypoxic three-dimensional cellular network construction replicates ex vivo the phenotype of primary human osteocytes. Tissue Eng Part A. 24:458–468. 2018. View Article : Google Scholar :
20	Mandatori D, Penolazzi L, Pipino C, Di Tomo P, Di Silvestre S, Di Pietro N, Trevisani S, Angelozzi M, Ucci M, Piva R and Pandolfi A: Menaquinone-4 enhances osteogenic potential of human amniotic fluid mesenchymal stem cells cultured in 2D and 3D dynamic culture systems. J Tissue Eng Regen Med. 12:447–459. 2018. View Article : Google Scholar
21	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar
22	Takeuchi T, Sugimoto A, Imazato N, Tamura M, Nakatani S, Kobata K and Arata Y: Glucosamine suppresses osteoclast differentiation through the modulation of glycosylation including O-GlcNAcylation. Biol Pharm Bull. 40:352–356. 2017. View Article : Google Scholar : PubMed/NCBI
23	Lv C, Wang L, Zhu X, Lin W, Chen X, Huang Z, Huang L and Yang S: Glucosamine promotes osteoblast proliferation by modulating autophagy via the mammalian target of rapamycin pathway. Biomed Pharmacother. 99:271–277. 2018. View Article : Google Scholar : PubMed/NCBI
24	Matsubara T, Kinbara M, Maeda T, Yoshizawa M, Kokabu S and Yamamoto TT: Regulation of osteoclast differentiation and actin ring formation by the cytolinker protein plectin. Biochem Biophys Res Commun. 489:472–476. 2017. View Article : Google Scholar : PubMed/NCBI
25	Luukkonen J, Hilli M, Nakamura M, Ritamo I, Valmu L, Kauppinen K, Tuukkanen J and Lehenkari P: Osteoclasts secrete osteopontin into resorption lacunae during bone resorption. Histochem Cell Biol. 151:475–487. 2019. View Article : Google Scholar : PubMed/NCBI
26	Chapurlat RD and Confavreux CB: Novel biological markers of bone: From bone metabolism to bone physiology. Rheumatology (Oxford). 55:1714–1725. 2016. View Article : Google Scholar
27	Jiang Z, Li Z, Zhang W, Yang Y, Han B, Liu W and Peng Y: Dietary natural N-Acetyl-d-Glucosamine prevents bone loss in ovariectomized rat model of postmenopausal osteoporosis. Molecules. 23:23022018. View Article : Google Scholar :
28	Ivanovska N and Dimitrova P: Bone resorption and remodeling in murine collagenase-induced osteoarthritis after administration of glucosamine. Arthritis Res Ther. 13:R442011. View Article : Google Scholar : PubMed/NCBI
29	Wang SX, Laverty S, Dumitriu M, Plaas A and Grynpas MD: The effects of glucosamine hydrochloride on subchondral bone changes in an animal model of osteoarthritis. Arthritis Rheum. 56:1537–1548. 2007. View Article : Google Scholar : PubMed/NCBI
30	Feng X and McDonald JM: Disorders of bone remodeling. Annu Rev Pathol. 6:121–145. 2011. View Article : Google Scholar
31	Kim BJ and Koh JM: Coupling factors involved in preserving bone balance. Cell Mol Life Sci. 76:1243–1253. 2019. View Article : Google Scholar
32	Nasri H, Baradaran A, Shirzad H and Rafieian-Kopaei M: New concepts in nutraceuticals as alternative for pharmaceuticals. Int J Prev Med. 5:1487–1499. 2014.
33	Daliu P, Santini A and Novellino E: From pharmaceuticals to nutraceuticals: Bridging disease prevention and management. Expert Rev Clin Pharmacol. 12:1–7. 2019. View Article : Google Scholar
34	Felson DT: Concerns about report suggesting glucosamine and chondroitin protect against cartilage loss. Ann Rheum Dis. 74:e382015. View Article : Google Scholar : PubMed/NCBI
35	Yang X and Qian K: Protein O-GlcNAcylation: Emerging mechanisms and functions. Nat Rev Mol Cell Biol. 18:452–465. 2017. View Article : Google Scholar : PubMed/NCBI
36	Herrero-Beaumont G and Largo R: Glucosamine and O-GlcNAcylation: A novel immunometabolic therapeutic target for OA and chronic, low-grade systemic inflammation? Ann Rheum Dis. 79:1261–1263. 2020. View Article : Google Scholar : PubMed/NCBI
37	Koyama T and Kamemura K: Global increase in O-linked N-acetylglucosamine modification promotes osteoblast differentiation. Exp Cell Res. 338:194–202. 2015. View Article : Google Scholar : PubMed/NCBI
38	Hart GW, Slawson C, Ramirez-Correa G and Lagerlof O: Cross talk between O-GlcNAcylation and phosphorylation: Roles in signaling, transcription, and chronic disease. Annu Rev Biochem. 80:825–858. 2011. View Article : Google Scholar : PubMed/NCBI